The manager's $1bn CFO created access for insurance investors that had lost the ability to back PE, while offering a compelling capital raising strategy for the firm itself.
Lazard’s acquisition of Campbell Lutyens proves scale matters. While there’s room at the top for more players, success will come with a price tag.
Apollo chief executive Marc Rowan’s comments this week point to a messy situation involving three of private markets’ hottest trends.
While the US Department of Labor’s March proposal flagged CVs as an area of concern in 401(k) plans, it should not be taken as a signal to rule them out.
Four debut strategies – including three focused on single-asset CV investments – ranked among the top 10 fundraises in Q1 2026. As LPs seek diversification, expect to see more of these funds drive figures.
Secondaries Investor will launch its inaugural Global Market Survey next week. While there’s agreement on the market’s future growth, there are diverging views on alignment.
Critics argue CVs entrench managers or delay inevitable exits. However, structured with transparency and fairness, these funds align interests rather than obscure them, writes AEA Investors' and Painswick Capital's John Garcia.
AI-driven tech disruptions have raised questions over the sustainability of the recent pricing recovery in venture secondaries.
A live deal by Carlyle is taking the concept of structured solutions to another level.
Managers who double down on the region and serve investors’ needs will stand better chances of harvesting success.